BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23566421)

  • 1. Genetic variation in GAD1 is associated with cortical thickness in the parahippocampal gyrus.
    Brauns S; Gollub RL; Walton E; Hass J; Smolka MN; White T; Wassink TH; Calhoun VD; Ehrlich S
    J Psychiatr Res; 2013 Jul; 47(7):872-9. PubMed ID: 23566421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT.
    Marenco S; Savostyanova AA; van der Veen JW; Geramita M; Stern A; Barnett AS; Kolachana B; Radulescu E; Zhang F; Callicott JH; Straub RE; Shen J; Weinberger DR
    Neuropsychopharmacology; 2010 Jul; 35(8):1708-17. PubMed ID: 20357758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression.
    Straub RE; Lipska BK; Egan MF; Goldberg TE; Callicott JH; Mayhew MB; Vakkalanka RK; Kolachana BS; Kleinman JE; Weinberger DR
    Mol Psychiatry; 2007 Sep; 12(9):854-69. PubMed ID: 17767149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMT and GAD1 gene polymorphisms are associated with impaired antisaccade task performance in schizophrenic patients.
    Kirenskaya AV; Storozheva ZI; Gruden MA; Sewell RDE
    Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):571-584. PubMed ID: 29429137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of catechol-O-methyltransferase variants to brain structure and function in a population at high risk of psychosis.
    McIntosh AM; Baig BJ; Hall J; Job D; Whalley HC; Lymer GK; Moorhead TW; Owens DG; Miller P; Porteous D; Lawrie SM; Johnstone EC
    Biol Psychiatry; 2007 May; 61(10):1127-34. PubMed ID: 17014827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol-O-methyltransferase Val(158)Met association with parahippocampal physiology during memory encoding in schizophrenia.
    Di Giorgio A; Caforio G; Blasi G; Taurisano P; Fazio L; Romano R; Ursini G; Gelao B; Bianco LL; Papazacharias A; Sinibaldi L; Popolizio T; Bellomo A; Bertolino A
    Psychol Med; 2011 Aug; 41(8):1721-31. PubMed ID: 21144115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-o-methyltransferase valine(158)methionine genotype and resting regional cerebral blood flow in medication-free patients with schizophrenia.
    Eisenberg DP; Sarpal D; Kohn PD; Meyer-Lindenberg A; Wint D; Kolachana B; Apud J; Weinberger DR; Berman KF
    Biol Psychiatry; 2010 Feb; 67(3):287-90. PubMed ID: 19892319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
    Shukla AA; Jha M; Birchfield T; Mukherjee S; Gleason K; Abdisalaam S; Asaithamby A; Adams-Huet B; Tamminga CA; Ghose S
    Schizophr Res; 2016 May; 173(1-2):94-100. PubMed ID: 27021555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the COMT genotype in the underlying functional brain activity of context processing in schizophrenia and in relatives.
    Lopez-Garcia P; Cristobal-Huerta A; Young Espinoza L; Molero P; Ortuño Sanchez-Pedreño F; Hernández-Tamames JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():176-82. PubMed ID: 27421706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prefrontal White Matter Structure Mediates the Influence of GAD1 on Working Memory.
    Lett TA; Kennedy JL; Radhu N; Dominguez LG; Chakravarty MM; Nazeri A; Farzan F; Walter H; Heinz A; Mulsant BH; Daskalakis ZJ; Voineskos AN
    Neuropsychopharmacology; 2016 Aug; 41(9):2224-31. PubMed ID: 26822489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between function and structure of the triple network and catechol-O-methyltransferase val
    Kang Y; Huang K; Cai S; Wang H; Liu J; Wang Y; Lv Y; Zhang W; Wang Q; Huang L; Wang J; Tian J
    Neurosci Lett; 2018 Nov; 687():65-70. PubMed ID: 30240822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the interaction between genetic variants of GAD1 and miRNA in bipolar disorders.
    Chung YE; Chen SC; Chuang LC; Shih WL; Chiu YH; Lu ML; Chen HC; Kuo PH
    J Affect Disord; 2017 Dec; 223():1-7. PubMed ID: 28710909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
    Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H
    Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia.
    Prata DP; Mechelli A; Fu CH; Picchioni M; Toulopoulou T; Bramon E; Walshe M; Murray RM; Collier DA; McGuire P
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13600-5. PubMed ID: 19666577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
    Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
    Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic study of association of four GABAergic genes: glutamic acid decarboxylase 1 gene, glutamic acid decarboxylase 2 gene, GABA(B) receptor 1 gene and GABA(A) receptor subunit beta2 gene, with schizophrenia using a universal DNA microarray.
    Zhao X; Qin S; Shi Y; Zhang A; Zhang J; Bian L; Wan C; Feng G; Gu N; Zhang G; He G; He L
    Schizophr Res; 2007 Jul; 93(1-3):374-84. PubMed ID: 17412563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders.
    Ehlis AC; Reif A; Herrmann MJ; Lesch KP; Fallgatter AJ
    Neuropsychopharmacology; 2007 Jan; 32(1):162-70. PubMed ID: 16823382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.
    Haraldsson HM; Ettinger U; Magnusdottir BB; Sigmundsson T; Sigurdsson E; Ingason A; Petursson H
    Schizophr Bull; 2010 Jan; 36(1):157-64. PubMed ID: 18562342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study on catechol-O-methyltransferase (COMT) Val158Met gene polymorphism and NEO-FFI.
    Aoki J; Iwahashi K; Ishigooka J; Ikeda K
    Psychiatry Res; 2011 May; 187(1-2):312-3. PubMed ID: 21051090
    [No Abstract]   [Full Text] [Related]  

  • 20. Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls.
    Raznahan A; Greenstein D; Lee Y; Long R; Clasen L; Gochman P; Addington A; Giedd JN; Rapoport JL; Gogtay N
    Neuroimage; 2011 Aug; 57(4):1517-23. PubMed ID: 21620981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.